ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Antipsychotic Selection
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
Psychiatrists have been buzzing about the CATIE trial ever since results were first published in 2005. Most non-psychiatrists are unaware of its widespread implications. What have we learned about antipsychotic selection? University of Michigan’s Director of Psychiatry Residency Education, Michael Jibson, MD discusses evidence based antipsychotic selection with host Dr. Leslie Lundt.
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Psychiatrists have been buzzing about the CATIE trial ever since results were first published in 2005. Most non-psychiatrists are unaware of its widespread implications. What have we learned about antipsychotic selection? University of Michigan’s Director of Psychiatry Residency Education, Michael Jibson, MD discusses evidence based antipsychotic selection with host Dr. Leslie Lundt.
Presenters
Facebook Comments